37 gedurende minimaal één maand voor de start van de behandeling en gedurende de dubbelblinde studie periode. ###>Background treatments for systemic sclerosis and digital ulcers were permitted if they remained constant for at least 1 month prior to the start of treatment and during the double-blind study period.